Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTYX Ventyx Biosciences, Inc.

休市中 03-14 16:00:00 EDT

1.41

+0.02

+1.44%

盘后1.42

+0.01+0.71%

19:28 EDT

最高1.44	最低1.39	成交量36.64万
今开1.42	昨收1.39	日振幅3.24%
总市值1.00亿	流通市值6,747万	总股本7,113万
成交额51.63万	换手率0.77%	流通股本4,785万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTYX","market":"US","secType":"STK","nameCN":"Ventyx Biosciences, Inc.","latestPrice":1.41,"timestamp":1741982400000,"preClose":1.39,"halted":0,"volume":366417,"hourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.41,"latestTime":"19:28 EDT","volume":3828,"amount":5408.0141,"timestamp":1741994917449},"delay":0,"floatShares":47853896,"shares":71130054,"eps":-1.973212,"marketStatus":"休市中","change":0.02,"latestTime":"03-14 16:00:00 EDT","open":1.42,"high":1.435,"low":1.39,"amount":516266.200128,"amplitude":0.032374,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.973212,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1742198400000},"marketStatusCode":7,"adr":0,"listingDate":1634788800000,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.41,"preClose":1.39,"latestTime":"09:27 EDT","volume":50,"amount":70.5,"timestamp":1741958824314},"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.41,"latestTime":"19:28 EDT","volume":3828,"amount":5408.0141,"timestamp":1741994917449},"volumeRatio":0.5960134016971891,"impliedVol":2.4727,"impliedVolPercentile":0.972},"requestUrl":"/m/hq/s/VTYX","defaultTab":"news","newsList":[{"id":"2518279807","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518279807?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:57","pubTimestamp":1741618653,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时57分，Ventyx Biosciences, Inc.股票出现异动，股价快速跳水5.03%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3502.57%、778.05%、728.02%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为111.00%、45.34%、41.36%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022573396404a1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022573396404a1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2518408994","title":"Ventyx Biosciences, Inc.2024财年实现净利润-1.35亿美元，同比增加30.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518408994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518408994?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449621,"startTime":"0","endTime":"0","summary":"3月9日，Ventyx Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-1.35亿美元，同比增加30.05%；其中营业收入为0.00美元，每股基本收益为-1.97美元。从资产负债表来看，Ventyx Biosciences, Inc.总负债24.62百万美元，其中短期债务1.05百万美元，资产负债比为0.12，流动比率为0.18。机构评级：截至2025年3月9日，当前有6家机构对Ventyx Biosciences, Inc.目标价做出预测，其中目标均价为8.67美元，其中最低目标价为1.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000036abef96f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000036abef96f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX"],"gpt_icon":0},{"id":"2516326046","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅下挫5.03%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516326046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516326046?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:50","pubTimestamp":1741013442,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时50分，Ventyx Biosciences, Inc.股票出现异动，股价急速下跌5.03%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Geovax Labs, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为502.76%、113.15%、83.67%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为140.46%、70.53%、35.60%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225042abe639a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225042abe639a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2514841351","title":"Ventyx Biosciences(VTYX.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.41美元，前值为-0.79美元，预期值为-0.54美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514841351","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514841351?lang=zh_cn&edition=full","pubTime":"2025-02-28 06:34","pubTimestamp":1740695696,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences(VTYX.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.41美元，前值为-0.79美元，预期值为-0.54美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28063448442488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VTYX"],"gpt_icon":0},{"id":"1149456577","title":"Ventyx Biosciences第四季度每股收益$(0.41)优于预期$(0.54)","url":"https://stock-news.laohu8.com/highlight/detail?id=1149456577","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149456577?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692807,"startTime":"0","endTime":"0","summary":"Ventyx Biosciences 报告季度亏损$每股，优于分析师一致预期的$，超过预期24.07%。与去年同期的每股亏损$相比，这是48.1%的增长。以上内容来自Benzinga Earnings专栏，原文如下：Ventyx Biosciences  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 24.07 percent. This is a 48.1 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ventyx Biosciences第四季度每股收益$(0.41)优于预期$(0.54)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX"],"gpt_icon":0},{"id":"2514330158","title":"Ventyx Biosciences, Inc.盘中异动 临近收盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514330158?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:48","pubTimestamp":1740689339,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时48分，Ventyx Biosciences, Inc.股票出现波动，股价快速下挫5.14%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1949.48%、415.28%、197.51%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044900989554bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044900989554bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2514011061","title":"Ventyx Biosciences, Inc.盘中异动 快速下跌5.16%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514011061?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:32","pubTimestamp":1740501175,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分，Ventyx Biosciences, Inc.股票出现异动，股价大幅下跌5.16%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1397.21%、1116.23%、914.13%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为241.19%、87.83%、66.67%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003255a253a278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003255a253a278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2511911572","title":"Ventyx Biosciences, Inc.盘中异动 临近收盘急速拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511911572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511911572?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:33","pubTimestamp":1739478812,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时33分，Ventyx Biosciences, Inc.股票出现波动，股价大幅拉升5.56%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3264.30%、2264.77%、1262.75%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214043332a244f1f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214043332a244f1f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2508141575","title":"Ventyx Biosciences, Inc.盘中异动 早盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141575?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:40","pubTimestamp":1738593646,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时40分，Ventyx Biosciences, Inc.股票出现波动，股价急速跳水5.01%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为380.98%、174.72%、61.68%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为82.67%、50.76%、33.33%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224047987970b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224047987970b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2507676090","title":"Ventyx Biosciences, Inc.盘中异动 急速拉升5.11%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507676090","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507676090?lang=zh_cn&edition=full","pubTime":"2025-01-31 01:39","pubTimestamp":1738258762,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日01时39分，Ventyx Biosciences, Inc.股票出现波动，股价大幅拉升5.11%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1729.06%、268.48%、230.82%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131013922abbd6c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131013922abbd6c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2507653129","title":"Ventyx Biosciences, Inc.盘中异动 临近午盘股价大跌5.20%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507653129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507653129?lang=zh_cn&edition=full","pubTime":"2025-01-30 00:32","pubTimestamp":1738168333,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日00时32分，Ventyx Biosciences, Inc.股票出现波动，股价大幅下挫5.20%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130003213a2337c53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130003213a2337c53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2506303231","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506303231?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:48","pubTimestamp":1737989338,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时48分，Ventyx Biosciences, Inc.股票出现波动，股价急速下跌5.11%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Pmgc Holdings Inc.较为活跃，换手率分别为1115.43%、150.52%、65.16%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为85.35%、65.16%、53.97%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272248599874b292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272248599874b292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2505861913","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.13%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505861913?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:55","pubTimestamp":1737730546,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时55分，Ventyx Biosciences, Inc.股票出现异动，股价急速跳水5.13%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Pmgc Holdings Inc.、Surrozen Inc C/Wts 01/08/2031 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Pmgc Holdings Inc.、Avenue Therapeutics, Inc.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1576.90%、880.78%、318.33%，振幅较大的相关个股有Pmgc Holdings Inc.、Dogwood Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为52.53%、33.18%、28.49%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225547a22e5fc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225547a22e5fc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2505877286","title":"Ventyx Biosciences, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505877286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505877286?lang=zh_cn&edition=full","pubTime":"2025-01-23 02:38","pubTimestamp":1737571111,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日02时38分，Ventyx Biosciences, Inc.股票出现波动，股价急速拉升5.05%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Nutriband Inc C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immunoprecise Antibodies Ltd.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为990.87%、322.40%、79.68%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Nutriband Inc C/Wts ，振幅分别为60.53%、53.51%、50.39%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123023831986f9e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123023831986f9e51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2505854177","title":"Ventyx Biosciences, Inc.盘中异动 下午盘大幅上涨5.20%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505854177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505854177?lang=zh_cn&edition=full","pubTime":"2025-01-22 03:41","pubTimestamp":1737488486,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日03时41分，Ventyx Biosciences, Inc.股票出现异动，股价大幅上涨5.20%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.81%。其相关个股中，Dogwood Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Camp4 Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为827.96%、523.80%、189.58%，振幅较大的相关个股有Channel Therapeutics Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Camp4 Therapeutics Corporation，振幅分别为96.32%、50.37%、46.97%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122034126986e687e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122034126986e687e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2504614577","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504614577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504614577?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:28","pubTimestamp":1737145706,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时28分，Ventyx Biosciences, Inc.股票出现异动，股价快速拉升5.03%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Aditxt, Inc.、Channel Therapeutics Corporation、Scorpius Holdings, Inc.较为活跃，换手率分别为245.97%、172.94%、98.20%，振幅较大的相关个股有Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Scorpius Holdings, Inc.，振幅分别为150.00%、117.68%、68.41%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118042827986a5dc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118042827986a5dc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2503891184","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503891184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503891184?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:40","pubTimestamp":1737042033,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时40分，Ventyx Biosciences, Inc.股票出现异动，股价急速下跌5.10%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623403496061758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623403496061758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2503010305","title":"HC Wainwright & Co.：重申Ventyx Biosciences(VTYX.US)评级，由中性调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503010305","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503010305?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:34","pubTimestamp":1736876047,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Ventyx Biosciences(VTYX.US)评级，由中性调整至中性评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15013447459168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VTYX"],"gpt_icon":0},{"id":"2503864065","title":"Ventyx Biosciences, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503864065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503864065?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:12","pubTimestamp":1736781138,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时12分，Ventyx Biosciences, Inc.股票出现异动，股价大幅下跌5.05%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为7155.75%、3729.08%、410.86%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.，振幅分别为193.80%、124.54%、106.07%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323121896025b5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323121896025b5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2502957408","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502957408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502957408?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:31","pubTimestamp":1736519494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时31分，Ventyx Biosciences, Inc.股票出现波动，股价急速下跌5.33%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为892.18%、130.65%、100.99%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Fractyl Health, Inc.、Septerna, Inc.，振幅分别为5.93%、5.72%、4.12%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102231349861e794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102231349861e794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.ventyxbio.com","stockEarnings":[{"period":"1week","weight":-0.0537},{"period":"1month","weight":-0.1296},{"period":"3month","weight":-0.3816},{"period":"6month","weight":-0.3843},{"period":"1year","weight":-0.8181},{"period":"ytd","weight":-0.3562}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0672},{"period":"3month","weight":-0.0685},{"period":"6month","weight":0.0014},{"period":"1year","weight":0.0929},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ventyx Biosciences, Inc.于2018年11月21日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为数百万患有炎症性疾病和自身免疫性疾病的患者开发新疗法。该公司相信，他们有选择性地调节关键免疫靶点以创造差异化药物的能力将使他们有可能破坏成熟的价值数十亿美元的商业市场，并使他们成为免疫学市场的领导者。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.032083},{"month":2,"riseRate":0.5,"avgChangeRate":0.472556},{"month":3,"riseRate":0.25,"avgChangeRate":-0.098843},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.042289},{"month":5,"riseRate":0.666667,"avgChangeRate":0.133308},{"month":6,"riseRate":0,"avgChangeRate":-0.288909},{"month":7,"riseRate":1,"avgChangeRate":0.12313},{"month":8,"riseRate":0.333333,"avgChangeRate":0.07183},{"month":9,"riseRate":0.666667,"avgChangeRate":0.241856},{"month":10,"riseRate":0,"avgChangeRate":-0.222243},{"month":11,"riseRate":0.25,"avgChangeRate":-0.186714},{"month":12,"riseRate":0.75,"avgChangeRate":0.025612}],"exchange":"NASDAQ","name":"Ventyx Biosciences, Inc.","nameEN":"Ventyx Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ventyx Biosciences, Inc.,VTYX,Ventyx Biosciences, Inc.股票,Ventyx Biosciences, Inc.股票老虎,Ventyx Biosciences, Inc.股票老虎国际,Ventyx Biosciences, Inc.行情,Ventyx Biosciences, Inc.股票行情,Ventyx Biosciences, Inc.股价,Ventyx Biosciences, Inc.股市,Ventyx Biosciences, Inc.股票价格,Ventyx Biosciences, Inc.股票交易,Ventyx Biosciences, Inc.股票购买,Ventyx Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}